monoclonal-antibody

Documents about monoclonal-antibody

• The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma#848198ClinicalTrials.gov
• Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults#993268ClinicalTrials.gov
• A Study of Anti-HIV Monoclonal Antibody KD-247#895209ClinicalTrials.gov
• A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors#885682ClinicalTrials.gov
• Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C#908027ClinicalTrials.gov
• Molecular interplay of insulin resistance and cancer: advances in monoclonal antibody therapeutics#651923Europe PMC
• Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Healthy Adult Subjects#913445ClinicalTrials.gov
• Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma#803524ClinicalTrials.gov
• A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid Arthritis#979062ClinicalTrials.gov
• Experimental and Computational Insight into the pH-Dependent Binding of Poly(glutamate)–Monoclonal Antibody Complexes for Biopharmaceutical Formulation#411828HAL (France)
• Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101#877145ClinicalTrials.gov
• Combination of Steroid and Humanized CD25 Monoclonal Antibody as First-line Therapy for aGVHD#901092ClinicalTrials.gov
• 3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption#869735ClinicalTrials.gov
• A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease#867560ClinicalTrials.gov
• EXCIPIENTS FOR ENHANCING MONOCLONAL ANTIBODY STABILITY IN ORAL SOLID DOSAGE FORMS#288533ScholarBank@NUS
• Adrecizumab-LPS Study#862341ClinicalTrials.gov
• MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD#874660ClinicalTrials.gov
• SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases#174873ClinicalTrials.gov
• Monoclonal anti-dsRNA antibody-based metagenomics (MADAM) reveal Pyricularia oryzae mycovirome#314151bioRxiv / medRxiv
• EGFR Monoclonal Antibody for Advanced Gastric Cancer#857918ClinicalTrials.gov
• Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI#1008271ClinicalTrials.gov
• Optimization strategies for monoclonal antibody production: advances in simulation and artificial intelligence in bioprocessing.#404592PubMed
• Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease#900497ClinicalTrials.gov
• Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer#967831ClinicalTrials.gov
• Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)#1008887ClinicalTrials.gov
• A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants#1008904ClinicalTrials.gov
• Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Chimeric Anti-CD20 Monoclonal Antibody in Patients With B-cell Non-Hodgkin's Lymphoma.#800204ClinicalTrials.gov
• Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies#442107ClinicalTrials.gov
• NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease#1008031ClinicalTrials.gov
• Study of CHO-A04 in Advanced Solid Tumors#833561ClinicalTrials.gov
• Optimization strategies for monoclonal antibody production: advances in simulation and artificial intelligence in bioprocessing#651931Europe PMC
• Study for Prevent Chronification Migraine Through Prediction of Response to Treatment With Anti-CGRP Antibodies#831363ClinicalTrials.gov
• First in class monoclonal antibody potentiating human follicle stimulating hormone activity improves spermatogenesis in azoospermic rodent models#304526HAL (France)
• A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)#831852ClinicalTrials.gov
• Experimental and computational analysis of glycan processing at increased monoclonal antibody productivities.#440715NCBI PubMed Central
• Anaphylaxis events following COVID-19 antiviral and neutralising monoclonal antibody treatment for non-hospitalised patients#452300LSHTM Data Compass
• Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.#827625ClinicalTrials.gov
• A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain#851712ClinicalTrials.gov
• Study of Nimotuzumab and Irinotecan in Metastatic Colorectal Cancer#855518ClinicalTrials.gov
• Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.#872472ClinicalTrials.gov
• Monoclonal Antibody-based Multipurpose Microbicides#905239ClinicalTrials.gov
• Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects#910224ClinicalTrials.gov
• Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer#915851ClinicalTrials.gov
• DyAb: sequence-based antibody design and property prediction in a low-data regime.#615980PubMed
• Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer#127670ClinicalTrials.gov
• Monoclonal Antibody Treatment for Systemic Lupus Erythematosus#377402ClinicalTrials.gov
• Complex intra-host SARS-CoV-2 evolution following monoclonal antibody pre-exposure prophylaxis#451904Europe PMC
• Pilot Study in Patients With Symptomatic Steroid-Naive Asthma#894216ClinicalTrials.gov
• A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors#838646ClinicalTrials.gov
• Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults#886337ClinicalTrials.gov